US 7790860
Targeting and imaging tumor vasculature using conjugates that bind to aminophospholipids
granted A61KA61K39/395A61K47/6849
Quick answer
US patent 7790860 (Targeting and imaging tumor vasculature using conjugates that bind to aminophospholipids) held by The Board of Regents of the University of Texas System expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K39/395, A61K47/6849, A61K51/1027